Comparison
GlaxoSmithKline Pakistan Limited vs The Searle Company Limited
In their latest annual results GLAXO reported revenue of Rs 65.9 bn (FY2025) and SEARL Rs 36.8 bn (FY2026). GLAXO trades at 9.5× earnings and SEARL at 103.7×. Dividend yields: GLAXO 5.4%, SEARL 1.3%.
| Latest | GLAXO FY2025 | SEARL FY2026 |
|---|---|---|
| Price | Rs 312.07 | Rs 77.75 |
| Market value | Rs 99.4 bn | — |
| P/E | 9.5× (stronger) | 103.7× |
| P/B | 2.89× | — |
| Dividend yield | 5.4% (stronger) | 1.3% |
| Revenue (latest year) | Rs 65.9 bn | Rs 36.8 bn |
| Revenue growth, year on year | 7.7% | 28.7% (stronger) |
| Revenue growth, 5 years a year | 13.4% (stronger) | 7.0% |
| Profit (latest year) | Rs 10.0 bn (stronger) | Rs 440.4 mn |
| EPS (latest year) | Rs 31.48 | Rs 0.75 |
| Dividend per share | Rs 17.00 | Rs 1.00 |
| Net margin | 15.2% (stronger) | 1.5% |
| Return on equity | 32.4% (stronger) | 1.3% |
| Debt to equity | 1.1% (stronger) | 23.4% |
| Current ratio | 2.32× (stronger) | 1.77× |
| Dividend streak (years) | 2 (stronger) | 1 |
Highlighted: the higher figure where higher is usually stronger (growth, margins, returns, yield) or the lower where lower is (P/E, P/B, debt). A highlight is a comparison, not a recommendation.
GLAXO
GlaxoSmithKline Pakistan Limited financial statements →
SEARL
The Searle Company Limited financial statements →
Related comparisons
Prices at the latest close; financial figures from each company's latest annual report. Information only, not investment advice.